Dr. Ansell on Combining CAR T-cell Therapy and Immunotherapy in Lymphomas
August 3rd 2017Stephen M. Ansell, MD, PhD, chair of the Lymphoma Group at Mayo Clinic, discusses the possibility of blending immunotherapy agents with chimeric antigen receptor (CAR) T-cell therapy across lymphoma populations.
Read More